Heidelberg Pharma AG (ETR:HPHA)
2.080
-0.070 (-3.26%)
Oct 26, 2026, 5:35 PM CET
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 33 employees as of August 31, 2026. The number of employees decreased by 78 or 70.27% compared to the same quarter last year. That makes Heidelberg Pharma AG the 36,790th largest employer in the world and 513th in Germany.
Employees
33
Change (1Y)
-78
Growth (1Y)
-70.27%
Revenue / Employee
€282,370
Profits / Employee
€906,166
Market Cap
97.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2026 | 33 | -78 | -70.27% |
| May 31, 2026 | 41 | -64 | -60.95% |
| Feb 28, 2026 | 60 | -45 | -42.86% |
| Nov 30, 2025 | 111 | 6 | 5.71% |
| Feb 28, 2025 | 105 | 7 | 7.14% |
| Nov 30, 2024 | 105 | 10 | 10.53% |
| Feb 29, 2024 | 98 | -2 | -2.00% |
| Nov 30, 2023 | 95 | -7 | -6.86% |
| Feb 28, 2023 | 100 | 11 | 12.36% |
| Nov 30, 2022 | 102 | 13 | 14.61% |
| May 31, 2022 | 93 | 6 | 6.90% |
| Feb 28, 2022 | 89 | 7 | 8.54% |
| Nov 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,486 |
| Bayer Aktiengesellschaft | 87,830 |
| Siemens Healthineers AG | 74,300 |
| Merck KGaA | 62,136 |
| MEDICLIN Aktiengesellschaft | 7,048 |
| FamiCord AG | 723 |
| DocCheck AG | 414 |
| LIMES Schlosskliniken AG | 314 |
Heidelberg Pharma AG News
- 11 days ago - EQS-News: Heidelberg Pharma Reports on the First Nine Months of Financial Year 2026 - Wallstreet:Online
- 11 days ago - Heidelberg Pharma AG Earnings release: Q3 2026 - Filings
- 1 month ago - EQS-Adhoc: Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates - Wallstreet:Online
- 3 months ago - Heidelberg Pharma AG Quarterly report: Q2 2026 - Filings
- 3 months ago - EQS-News: Heidelberg Pharma Reports on First Half-Year 2026 and the Positive Course of Business - Wallstreet:Online
- 6 months ago - EQS-News: Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026 - Wallstreet:Online
- 6 months ago - Heidelberg Pharma AG Earnings release: Q1 2026 - Filings
- 6 months ago - EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101 - Wallstreet:Online